ACAD · Categories · Form 3

ACAD - SEC Form 3 initial insider statements

ACADIA Pharmaceuticals Inc. (ACAD) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for ACAD

• 79d
  SEC Form 3 filed by new insider Poole Jonathan

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 544d
  SEC Form 3 filed by new insider Garner Thomas

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 620d
  SEC Form 3 filed by new insider Adams Catherine Owen

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 783d
  SEC Form 3 filed by new insider Thompson Elizabeth H.Z.

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 850d
  SEC Form 3 filed by new insider Rhodes Jennifer J

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 1210d
  SEC Form 3 filed by new insider Williamson Douglas J

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 1332d
  SEC Form 3 filed by new insider Ndu Adora

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 1630d
  SEC Form 3: New insider Schneyer Mark C. claimed ownership of 1,303 shares

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)
• 1675d
  SEC Form 3: New insider Teehan Brendan claimed ownership of 807 shares

  3 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

Other ACAD categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends